The Plastic Surgery Foundation
Log In Donate Now
 

Grants We Funded

Grant applicants for the 2023 cycle requested a total of nearly $4 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated nearly 140 grant applications on the following topics:

The PSF awarded research grants totaling over $1 million dollars to support nearly 30 plastic surgery research proposals.

ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.

Research Abstracts

Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.

Adipose Stem Cells: A Distinct Population of Just Migratory Stem Cells

Principal Investigator
Bret Schipper MD

Year
2007

Institution
University of Pittsburgh

Funding Mechanism
Basic Research Grant

Focus Area
Tissue Engineering

Abstract
This study is designed to determine whether adipose derived stem cells are primarily derived in adipose tissue during embryogenesis and are a distinct cell population, or whether the multipotent cells in adipose tissue represent bone marrow stem cells that have migrated into adipose depots. We hypothesize that adipose derived stem cells are indeed a distinct population and not simply migratory bone marrow cells. This knowledge has broad applications to the development of cell based therapies, especially therapies for the treatment of hematopoietic malignancies. Autologous adipose stem cells (ACS's) could be used in place of allogeneic bone marrow transplantation in the setting of bone marrow dyscrasias. This would greatly decrease the morbidity and mortality of using bone marrow transplants.